To contribute to improvement of public health by its high quality of research, IPS-CAS established a number of collaboration projects with industry. IPS-CAS and its incubator-Advance BioChina aims to become a cluster in China for biotechnology companies worldwide by providing technical expertise, research platform and a privilege access for collaboration with laboratories and hospitals. The priority areas for collaboration are in particular to develop vaccine, therapy and diagnosis products against infectious diseases (viral hepatitis, avian flu, multi-resistance tuberculosis).

On the occasion of the inauguration, Mr. President Hollande witnessed the signatures of MOU between IPS-CAS and Taicang People’s Government, BioMérieux, Wuxi Apptec and Tianyi Group respectively.

Being a bridge of Sino-French cooperation, IPS shall continue to contribute to the cause of human science, said Hollande

Inauguration for IPS new building

Lab visiting

MOU signing ceremony (with Taicang People’s Government)

MOU signing ceremony (with BioMérieux)

MOU signing ceremony (with Wuxi Apptec)

MOU signing ceremony (with Tianyi Group）